Related Experiment Videos
Are acquired nevi oestrogen-dependent tumours?
G B Jemec1, B S Bhogal, F Wojnarowska
1Department of Dermatology, Slade Hospital, Oxford, England.
Acta Dermato-Venereologica
|January 1, 1987
Summary
This study investigated estrogen receptors in benign acquired nevi. Researchers found no evidence of estrogen dependence, suggesting nevi are not estrogen-driven tumors.
Area of Science:
- Oncology
- Endocrinology
- Dermatology
Background:
- Estrogen receptors are implicated in various cancers.
- The role of estrogen in benign acquired nevi development is not fully understood.
- The p29 protein is a cytoplasmic marker in estrogen-sensitive cells.
Purpose of the Study:
- To investigate the presence and binding of the ER D5 monoclonal antibody in benign acquired nevi.
- To determine if acquired nevi exhibit estrogen sensitivity.
- To evaluate the hypothesis that acquired nevi are not estrogen-dependent tumors.
Main Methods:
- Analysis of twelve benign acquired nevi samples.
- Utilizing the ER D5 monoclonal antibody for specific protein binding detection.
- Immunohistochemical staining to identify p29 protein presence in nevoid cells.
Main Results:
- No specific binding of the ER D5 monoclonal antibody was observed in the studied nevi cells.
- Absence of the p29 protein, a marker for estrogen-sensitive cells, was noted in nevoid cells.
- The findings indicate a lack of estrogen receptor expression in benign acquired nevi.
Conclusions:
- Acquired nevi do not appear to be estrogen-dependent tumors.
- The study supports the hypothesis that estrogen does not play a significant role in the development of benign acquired nevi.
- Further research may explore alternative pathways in nevus development.